{
    "organizations": [],
    "uuid": "a70a12ae3b5fc1ca35a1a848130030f2ec0e2e5b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-carmat-continuing-progress-in-line/brief-carmat-continuing-progress-in-line-with-objective-of-obtaining-ce-marking-in-2019-idUSFWN1RI00S",
    "ord_in_thread": 0,
    "title": "BRIEF-Carmat Continuing Progress In Line With Objective Of Obtaining CE Marking In 2019",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - Carmat SA:\n* OPENING OF NEW BOIS-D’ARCY SITE FOR LARGE-SCALE PRODUCTION OF PROSTHESES\n* PRE-SUBMISSION OF AN EARLY FEASIBILITY STUDY REQUEST WITH U.S. FDA IN ORDER TO INITIATE IMPLANTS IN UNITED STATES\n* ‍PIVOTAL STUDY RECRUITMENT PACE ACCELERATING WITH 30% OF TOTAL NUMBER OF PLANNED PATIENTS IMPLANTED​\n* RAMPING UP OUR PROJECT ON ALL OF ITS STRATEGIC ROUTES * CONTINUING PROGRESS IN LINE WITH OBJECTIVE OF OBTAINING CE MARKING IN 2019\n ",
    "published": "2018-04-05T13:03:00.000+03:00",
    "crawled": "2018-04-06T21:52:05.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "carmat",
        "sa",
        "opening",
        "new",
        "arcy",
        "site",
        "production",
        "prosthesis",
        "early",
        "feasibility",
        "study",
        "request",
        "fda",
        "order",
        "initiate",
        "implant",
        "united",
        "state",
        "study",
        "recruitment",
        "pace",
        "accelerating",
        "total",
        "number",
        "planned",
        "patient",
        "ramping",
        "project",
        "strategic",
        "route",
        "continuing",
        "progress",
        "line",
        "objective",
        "obtaining",
        "ce",
        "marking"
    ]
}